Therapeutics Acquisition Corporation (TXAC)

Aug 6, 2020 - Stock symbol was changed to RACA

Stock Price: $12.96 USD 0.00 (0.00%)

Updated Aug 6, 2020 4:00 PM EDT

Stock Price Chart

Key Info

Market Cap	196.81M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	15.19M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Dividend Yield	n/a

Stock Quote

Trading Day	Aug 6, 2020
Last Price	$12.96
Previous Close	$12.96
Change ($)	0.00
Change (%)	0.00%
Day's Open	-
Day's Range	12.21 - 13.10
Day's Volume	0
52-Week Range	11.11 - 21.44

More Stats

Market Cap	196.81M
Enterprise Value	n/a
Earnings Date (est)	n/a
Ex-Dividend Date	n/a
Shares Outstanding	15.19M
Float	n/a
EPS (basic)	n/a
EPS (diluted)	n/a
FCF / Share	n/a

Dividend	n/a
Dividend Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a
Payout Ratio	n/a
Shares Short	47,379
Short Ratio	0.28
Short % of Float	n/a
Beta	n/a

PE Ratio	n/a
Forward PE	n/a
P/FCF Ratio	n/a
PS Ratio	n/a
PB Ratio	n/a
Revenue	n/a
Operating Income	n/a
Net Income	n/a
Free Cash Flow	n/a

Net Cash	n/a
Net Cash / Share	n/a
Gross Margin	n/a
Operating Margin	n/a
Profit Margin	n/a
FCF Margin	n/a
ROA	n/a
ROE	n/a
ROIC	n/a

Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy	0
Overweight	0
Hold	0
Underweight	0
Sell	0

What these ratings mean

Analyst Consensus: n/a

Price Target

$n/a*

*No analysts have provided price targets for this stock.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name	Therapeutics Acquisition Corporation
Country	United States
CEO	Peter Kolchinsky

Stock Information

Ticker Symbol	TXAC
Stock Exchange	NASDAQ
Sector	Financial Services
Industry	Shell Companies
Unique Identifier	NASDAQ: TXAC
IPO Date	July 8, 2020

Description

Therapeutics Acquisition focuses on merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify and acquire a business focusing on the healthcare industry. The company was founded in 2020 and is based in Boston, Massachusetts.